Katzoff David J 4
4 · Alzamend Neuro, Inc. · Filed Sep 26, 2023
Insider Transaction Report
Form 4
Katzoff David J
Chief Financial Officer
Transactions
- Purchase
Common Stock
2023-09-26$0.19/sh+53,000$10,234→ 81,000 total
Footnotes (1)
- [F1]The common stock was bought by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $0.1931. The range of purchase prices on the transaction date was $0.19 to $0.1955 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares bought at each price.